CroíValve Announces $16 Million Equity Financing to Fund US Early Feasibility Study of Novel Transcatheter Tricuspid Device

Contributed by: Business Wire

Logo

Business Wire logo

Images

Business Wire embedded0

Tags

Research
Professional Services
Technology
Medical Devices
Clinical Trials
Science
Cardiology
Biotechnology
FDA
Finance
Other Technology
Health
Other Science
Medical

More Like This

Business Wire logo

ReValve Solutions Announces Successful First-in-Human with Next Generation TMVR Technology

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

PR Newswire associated0

Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval

PR Newswire associated0

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

Jenscare, with innovative TTVR, releases 2024H1 interim results

The 1-Year Follow-up Results of LuX-Valve Plus were Officially Released at TCT 2024

PR Newswire associated0

NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation

Novostia Announces New CEO and Secures Additional CHF 5.6 million in Funding